This company listing is no longer active
MDFZ.F Stock Overview
Medifocus, Inc., a medical technology company, develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate in Canada and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Medifocus, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0059 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -99.97% |
| 3 Year Change | -100.00% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| MDFZ.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -0.2% | 1.3% |
| 1Y | -100.0% | 10.6% | 29.8% |
Return vs Industry: MDFZ.F underperformed the US Medical Equipment industry which returned -24.2% over the past year.
Return vs Market: MDFZ.F underperformed the US Market which returned -12.7% over the past year.
Price Volatility
| MDFZ.F volatility | |
|---|---|
| MDFZ.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: MDFZ.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MDFZ.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | William Jow | https://www.medifocusinc.com |
Medifocus, Inc., a medical technology company, develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate in Canada and the United States. The company owns technology platforms, including Endo-thermotherapy platform, a catheter-based focused heat technology platform that utilizes natural body openings to deliver microwave thermotherapy to the diseased sites; and Adaptive Phased Array (APA) Microwave Focusing platform, which directs focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue. It also offers Prolieve Thermodilatation system, a medical device based on endo-thermotherapy for the treatment of benign prostatic hyperplasia.
Medifocus, Inc. Fundamentals Summary
| MDFZ.F fundamental statistics | |
|---|---|
| Market cap | US$184.00 |
| Earnings (TTM) | -US$1.93m |
| Revenue (TTM) | US$2.23m |
0.0x
P/S Ratio0.0x
P/E RatioIs MDFZ.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDFZ.F income statement (TTM) | |
|---|---|
| Revenue | US$2.23m |
| Cost of Revenue | US$1.58m |
| Gross Profit | US$656.97k |
| Other Expenses | US$2.59m |
| Earnings | -US$1.93m |
Last Reported Earnings
Dec 31, 2019
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did MDFZ.F perform over the long term?
See historical performance and comparison